Physician profile
Patrick Bockenstedt
NPI 1689938078
$984.56
in general payments reported to CMS, 2019-2025
19 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $167 · 2021: $88.95 · 2022: $18.43 · 2023: $159 · 2024: $85.29 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $303.40 | 2019-2025 | |
| Genzyme Corporation | $190.45 | 2019-2025 | |
| Stryker Corporation | $113.93 | 2019-2024 | Clarifix Cryotherapy Device |
| Novartis Pharmaceuticals Corporation | $64.43 | 2019 | |
| Baxter Healthcare | $39.83 | 2025 | Perclot |
| Regeneron Healthcare Solutions, INC. | $30.90 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $30.61 | 2025 | Voquezna |
| Glenmark Therapeutics INC. | $28.00 | 2019 | |
| Aerin Medical INC. | $23.63 | 2023 | |
| Hologic Sales and Service, LLC | $23.51 | 2023 | Coolseal Generator |
| Amgen INC. | $20.19 | 2025 | |
| Arbor Pharmaceuticals, INC. | $18.46 | 2019 | |
| Alk-Abello, INC | $17.67 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $16.21 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $15.93 | 2025 | Nucala |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.66 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.69 | 2020 | |
| Medtronic USA, INC. | $11.47 | 2019 | |
| Fortovia Therapeutics, INC. | $5.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Bockenstedt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.